March 14, 2013
The 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) has come and gone. While we enjoyed a healthy dose of warm southern hospitality, a world-class aquarium and great food, a lot of ground-breaking medical and scientific news was presented. If you didn't have the opportunity to make the trip to Atlanta (only ~4,000 were given that coveted admission), here's a quick review of what we thought were the top 10 presentations (divided across seven topic areas) likely to have a lingering impact.
Table of Contents
Josep M. Llibre, M.D., is in the HIV Unit of the "Lluita contra la SIDA" Foundation at University Hospital Germans Trias I Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain. Dr. Llibre has received funding for research or payment for conferences or participation on advisory boards from Abbott, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Janssen-Cilag, Merck Sharp & Dohme, and ViiV Healthcare.
Benjamin Young, M.D., Ph.D., is vice president and chief medical officer of the International Association of Providers of AIDS Care based in Washington, D.C., and an adjunct professor at the Josef Korbel School of International Studies at the University of Denver. Dr. Young has received consulting or speaking fees from Bristol-Myers Squibb, Cerner Corporation, Gilead Sciences, GlaxoSmithKline, Merck & Co., Monogram Biosciences and ViiV Healthcare. He has received research funding from Bristol-Myers Squibb Company, Cerner Corporation, Gilead Sciences, GlaxoSmithKline, Merck & Co., and ViiV Healthcare.
No comments have been made.
|Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.|